Nektar Therapeutics (NKTR)

CIK 906709 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Nektar Therapeutics.

Recent SEC filings

FiledFormAccession number
Oct 20, 2026S-80001213900-26-110774
Oct 1, 20268-K0001213900-26-105453
Sep 28, 2026SCHEDULE 13G/A0001193125-26-403411
Sep 25, 20268-K0001213900-26-103215
Sep 25, 202640001193125-26-403103
Sep 25, 202640001193125-26-403105
Sep 25, 202640001193125-26-403101
Sep 25, 202640001193125-26-403099
Sep 25, 202640001193125-26-403097
Sep 8, 20268-K0001213900-26-098042
Aug 20, 202640001193125-26-359588
Aug 20, 202640001193125-26-359586
Aug 18, 20261440001959173-26-006172
Aug 18, 20261440001959173-26-006164
Aug 14, 2026SCHEDULE 13G/A0000921895-26-002174
Aug 14, 202610-Q0001193125-26-349805
Aug 14, 2026S-80001213900-26-090164
Aug 14, 2026SCHEDULE 13G/A0001011438-26-000548
Aug 13, 20268-K0001213900-26-089137
Jul 31, 2026SCHEDULE 13G0002100119-26-001473
Jul 29, 2026SCHEDULE 13G0002012383-26-002912
Jul 24, 202640001193125-26-316458
Jul 24, 202640001193125-26-316457
Jul 2, 202640001193125-26-295112
Jun 30, 20261440001950047-26-006656